Business model

Enable sustainable pipeline expansion and secure revenue sources using innovative drug discovery platform technology

In recent years, Sosei has brought subsidiary companies with innovative drug discovery platform technologies into the Group through M&A. We aim to benefit society by advancing innovative therapies to patients as quickly as possible, so we commercialize via various routes including progressing R&D based on the drug discovery technologies of our subsidiaries, supplying technology to other companies, developing products in-house, and product licensing.